Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Nadiyah Alqazlan, Jake Astill, Sugandha Raj & Shayan Sharif. (2022) Strategies for enhancing immunity against avian influenza virus in chickens: a review. Avian Pathology 51:3, pages 211-235.
Read now
Read now
Vânia Rodrigues Leite-Silva, Mariana Mandelli de Almeida, Aurélie Fradin, Jeffrey Ernest Grice & Michael Stephen Roberts. (2012) Delivery of drugs applied topically to the skin. Expert Review of Dermatology 7:4, pages 383-397.
Read now
Read now
Myrra G. Carstens, Koen van der Maaden,Daniel van der Velden,Tom H.M. Ottenhoff, Cornelis J. Melief, Ferry Ossendorp, Joke A. Bouwstra & Wim Jiskoot. (2011) Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes. Journal of Liposome Research 21:4, pages 286-295.
Read now
Read now
Julieta Gasparri, Lucía Speroni, Nadia Silvia Chiaramoni & Silvia del Valle Alonso. (2011) Relationship between the adjuvant and cytotoxic effects of the positive charges and polymerization in liposomes. Journal of Liposome Research 21:2, pages 124-133.
Read now
Read now
Dennis Christensen, Karen Smith Korsholm, Peter Andersen & Else Marie Agger. (2011) Cationic liposomes as vaccine adjuvants. Expert Review of Vaccines 10:4, pages 513-521.
Read now
Read now
Malou Henriksen-Lacey, Karen Smith Korsholm, Peter Andersen, Yvonne Perrie & Dennis Christensen. (2011) Liposomal vaccine delivery systems. Expert Opinion on Drug Delivery 8:4, pages 505-519.
Read now
Read now
Girishchandra B Patel & Wangxue Chen. (2010) Archaeal lipid mucosal vaccine adjuvant and delivery system. Expert Review of Vaccines 9:4, pages 431-440.
Read now
Read now
Joost H. van den Berg, Bastiaan Nuijen, Ton N. Schumacher, John B.A.G. Haanen, Gert Storm, Jos H. Beijnen & Wim E. Hennink. (2010) Synthetic vehicles for DNA vaccination. Journal of Drug Targeting 18:1, pages 1-14.
Read now
Read now
Dennis Christensen, Else Marie Agger, Lars Vibe Andreasen, Daniel Kirby, Peter Andersen & Yvonne Perrie. (2009) Liposome-based cationic adjuvant formulations (CAF): Past, present, and future. Journal of Liposome Research 19:1, pages 2-11.
Read now
Read now
Sudipta Bhowmick & Nahid Ali. (2008) Recent developments in leishmaniasis vaccine delivery systems. Expert Opinion on Drug Delivery 5:7, pages 789-803.
Read now
Read now
Articles from other publishers (99)
Marie-Clotilde Bernard, Emilie Bazin, Nadine Petiot, Katia Lemdani, Sylvie Commandeur, Cécile Verdelet, Sylvie Margot, Vladimir Perkov, Manon Ripoll, Marie Garinot, Sophie Ruiz, Florence Boudet, Bachra Rokbi & Jean Haensler. (2023) The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system. Molecular Therapy - Nucleic Acids 32, pages 794-806.
Crossref
Crossref
Hanjin Seo, Leekang Jeon, Jaeyeong Kwon & Hyomin Lee. (2023) High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications. Advanced Healthcare Materials 12:13.
Crossref
Crossref
Allegra Peletta, Céline Lemoine, Thomas Courant, Nicolas Collin & Gerrit Borchard. (2023) Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines. Pharmacological Research 189, pages 106699.
Crossref
Crossref
Siva K. Gandhapudi, Hua Shi, Martin R. Ward, John Peyton Bush, Margarita Avdiushko, Karuna Sundarapandiyan, Lauren V. Wood, Mania Dorrani, Afsheen Fatima, Joe Dervan, Frank Bedu-Addo, Greg Conn, Ted M. Ross & Jerold G. Woodward. (2023) Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. Viruses 15:2, pages 432.
Crossref
Crossref
Hans Warmenhoven, Romain Leboux, Athanasios Bethanis, Jolinde van Strien, Adrian Logiantara, Hans van Schijndel, Lorenz Aglas, Leonie van Rijt, Bram Slütter, Alexander Kros, Wim Jiskoot & Ronald van Ree. (2023) Cationic liposomes bearing Bet v 1 by coiled coil-formation are hypo-allergenic and induce strong immunogenicity in mice. Frontiers in Allergy 3.
Crossref
Crossref
Z. Kabarkouhi, M. Mehrarya, B. Gharehchelou, Z. Jalilian, R. Jalili, M.N. Wintrasiri & M.R. Mozafari. (2023) Liposome, Nanoliposome and Allied Technologies in Covid-19 Vaccines:
Key Roles and Functionalities. Current Drug Delivery 20:1, pages 3-7.
Crossref
Crossref
Anwesha Barik & Sanjay Dey. 2023. Infectious Diseases Drug Delivery Systems. Infectious Diseases Drug Delivery Systems
147
168
.
Harun Achmad, Yousif Saleh Ibrahim, Muataz Mohammed Al-Taee, Gamal A. Gabr, Muhammad Waheed Riaz, Shadia Hamoud Alshahrani, Andrés Alexis Ramírez-Coronel, Abduladheem Turki Jalil, Hendrik Setia Budi, Windi Sawitri, Malyutina Elena Stanislavovna & Jitendra Gupta. (2022) Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting. International Immunopharmacology 113, pages 109434.
Crossref
Crossref
Abdul Rahim Ferhan, Soohyun Park, Hyeonjin Park, Hyunhyuk Tae, Joshua A. Jackman & Nam‐Joon Cho. (2022) Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective. Advanced Functional Materials 32:37.
Crossref
Crossref
Shugang Qin, Xiaoshan Tang, Yuting Chen, Kepan Chen, Na Fan, Wen Xiao, Qian Zheng, Guohong Li, Yuqing Teng, Min Wu & Xiangrong Song. (2022) mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Fernando Lozano Vigario, Noémi Anna Nagy, Meike H. The, Rinske Sparrius, Joke A. Bouwstra, Alexander Kros, Wim Jiskoot, Esther C. de Jong & Bram Slütter. (2022) The Use of a Staggered Herringbone Micromixer for the Preparation of Rigid Liposomal Formulations Allows Efficient Encapsulation of Antigen and Adjuvant. Journal of Pharmaceutical Sciences 111:4, pages 1050-1057.
Crossref
Crossref
Anh Thi Tram Tu, Kazuaki Hoshi, Miwako Shobo & Tomohiko Yamazaki. (2022) G-quadruplex-based CpG oligodeoxynucleotide/DOTAP complex strongly stimulates immunity in CpG motif-specific and loop-length-dependent manners. Nanomedicine: Nanotechnology, Biology and Medicine 40, pages 102508.
Crossref
Crossref
Nabendu Debnath, Mony Thakur, Khushboo, Neelam P. Negi, Vibhav Gautam, Ashok Kumar Yadav & Deepak Kumar. (2021) Insight of oral vaccines as an alternative approach to health and disease management: An innovative intuition and challenges. Biotechnology and Bioengineering 119:2, pages 327-346.
Crossref
Crossref
Kacper Karczmarzyk & Małgorzata Kęsik-Brodacka. (2022) Attacking the Intruder at the Gate: Prospects of Mucosal Anti SARS-CoV-2 Vaccines. Pathogens 11:2, pages 117.
Crossref
Crossref
Mohamed Ahmed Attia, Ebtessam Ahmed Essa, Toka Tarek Elebyary, Ahmed Mostafa Faheem & Amal Ali Elkordy. (2021) Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines. Pharmaceuticals 14:11, pages 1173.
Crossref
Crossref
Yuebao Zhang, Changzhen Sun, Chang Wang, Katarina E. Jankovic & Yizhou Dong. (2021) Lipids and Lipid Derivatives for RNA Delivery. Chemical Reviews 121:20, pages 12181-12277.
Crossref
Crossref
Mona Yazdani, Amin Reza Nikpoor, Zahra Gholizadeh, Nema Mohamadian Roshan, Alexander Seifalian, Mahmoud Reza Jaafari & Ali Badiee. (2021) Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model. International Immunopharmacology 98, pages 107833.
Crossref
Crossref
Danielle E. Large, Rudolf G. Abdelmessih, Elizabeth A. Fink & Debra T. Auguste. (2021) Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Advanced Drug Delivery Reviews 176, pages 113851.
Crossref
Crossref
Romain J. T. Leboux, Pim Schipper, Toni M. M. van Capel, Lily Kong, Koen van der Maaden, Alexander Kros, Wim Jiskoot, Esther C. de Jong & Joke A. Bouwstra. (2021) Antigen Uptake After Intradermal Microinjection Depends on Antigen Nature and Formulation, but Not on Injection Depth. Frontiers in Allergy 2.
Crossref
Crossref
Basmah N. Aldosari, Iman M. Alfagih & Alanood S. Almurshedi. (2021) Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics 13:2, pages 206.
Crossref
Crossref
Reza Keikha, Karim Daliri & Ali Jebali. (2021) The Use of Nanobiotechnology in Immunology and Vaccination. Vaccines 9:2, pages 74.
Crossref
Crossref
R.J.T. Leboux, N. Benne, W.L. van Os, J. Bussmann, A. Kros, W. Jiskoot & B. Slütter. (2021) High-affinity antigen association to cationic liposomes via coiled coil-forming peptides induces a strong antigen-specific CD4+ T-cell response. European Journal of Pharmaceutics and Biopharmaceutics 158, pages 96-105.
Crossref
Crossref
Monika Rak, Anna Góra-Sochacka & Zbigniew Madeja. 2021. Vaccine Delivery Technology. Vaccine Delivery Technology
391
404
.
Ruslan Kashapov, Gulnara Gaynanova, Dinar Gabdrakhmanov, Denis Kuznetsov, Rais Pavlov, Konstantin Petrov, Lucia Zakharova & Oleg Sinyashin. (2020) Self-Assembly of Amphiphilic Compounds as a Versatile Tool for Construction of Nanoscale Drug Carriers. International Journal of Molecular Sciences 21:18, pages 6961.
Crossref
Crossref
Santos Ramírez-Carreto, Beatriz Miranda-Zaragoza & Claudia Rodríguez-Almazán. (2020) Actinoporins: From the Structure and Function to the Generation of Biotechnological and Therapeutic Tools. Biomolecules 10:4, pages 539.
Crossref
Crossref
David Nardo, David Henson, Joe E. Springer & Vincent J. Venditto. 2020. Nanomaterials for Clinical Applications. Nanomaterials for Clinical Applications
159
211
.
Joon Haeng Rhee. 2020. Mucosal Vaccines. Mucosal Vaccines
325
356
.
Gustavo Lou, Giulia Anderluzzi, Stuart Woods, Craig W. Roberts & Yvonne Perrie. (2019) A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations. European Journal of Pharmaceutics and Biopharmaceutics 143, pages 51-60.
Crossref
Crossref
Xuanjin Wu, Yang Li, Xiguang Chen, Zhongzheng Zhou, Jianhui Pang, Xin Luo & Ming Kong. (2019) A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization. Journal of Materials Chemistry B 7:31, pages 4854-4866.
Crossref
Crossref
Rita Vanbever, Cristina Loira-Pastoriza, Nicolas Dauguet, Caroline Hérin, Saloua Ibouraadaten, Kevin Vanvarenberg, Bernard Ucakar, Donatienne Tyteca & François Huaux. (2019) Cationic Nanoliposomes Are Efficiently Taken up by Alveolar Macrophages but Have Little Access to Dendritic Cells and Interstitial Macrophages in the Normal and CpG-Stimulated Lungs. Molecular Pharmaceutics 16:5, pages 2048-2059.
Crossref
Crossref
Farzad Khademi, Amirhossein Sahebkar, Mahdi Fasihi-Ramandi & Ramezan Ali Taheri. (2018)
Induction of strong immune response against a multicomponent antigen of
Mycobacterium tuberculosis
in BALB/c mice using PLGA and DOTAP adjuvant
. APMIS 126:6, pages 509-514.
Crossref
Crossref
Iman Jafari, Vahid Heravi Shargh, Maryam Shahryari, Azam Abbasi, Mahmoud Reza Jaafari, Ali Khamesipour & Ali Badiee. (2018) Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model. Immunobiology 223:6-7, pages 493-500.
Crossref
Crossref
Anđelka B. Kovačević, Sérgio M.C. Silva & Slavomira Doktorovová. 2018. Emerging Nanotechnologies in Immunology. Emerging Nanotechnologies in Immunology
103
133
.
Farzad Khademi, Ramezan Ali Taheri, Amir Abbas Momtazi-Borojeni, Gholamreza Farnoosh, Thomas P. Johnston & Amirhossein Sahebkar. 2018. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175
47
69
.
Anna Stachyra, Monika Rak, Patrycja Redkiewicz, Zbigniew Madeja, Katarzyna Gawarecka, Tadeusz Chojnacki, Ewa Świeżewska, Marek Masnyk, Marek Chmielewski, Agnieszka Sirko & Anna Góra-Sochacka. (2017) Effective usage of cationic derivatives of polyprenols as carriers of DNA vaccines against influenza virus. Virology Journal 14:1.
Crossref
Crossref
Yasmin Granot & Dan Peer. (2017) Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint. Seminars in Immunology 34, pages 68-77.
Crossref
Crossref
Kan Kaneko, Arlene McDowell, Yasuyuki Ishii & Sarah Hook. (2017) Liposomal α-galactosylceramide is taken up by gut-associated lymphoid tissue and stimulates local and systemic immune responses. Journal of Pharmacy and Pharmacology 69:12, pages 1724-1735.
Crossref
Crossref
Helmy Yusuf, Ahlam A. Ali, Natalie Orr, Michael M. Tunney, Helen O. McCarthy & Vicky L. Kett. (2017) Novel freeze-dried DDA and TPGS liposomes are suitable for nasal delivery of vaccine. International Journal of Pharmaceutics 533:1, pages 179-186.
Crossref
Crossref
Markus Riehl, Meike Harms, Andrea Hanefeld, Renato B. Baleeiro, Peter Walden & Karsten Mäder. (2017) Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies. International Journal of Pharmaceutics 532:1, pages 37-46.
Crossref
Crossref
N. Marasini, K.A. Ghaffar, M. Skwarczynski & I. Toth. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
221
239
.
Ruchi R. Shah, Kimberly J. Hassett & Luis A. Brito. 2017. Vaccine Adjuvants. Vaccine Adjuvants
1
13
.
Kuan-Yin Shen, Hsin-Yu Liu, Hui-Ju Li, Chiao-Chieh Wu, Gunn-Guang Liou, Yuan-Chih Chang, Chih-Hsiang Leng & Shih-Jen Liu. (2016) A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity. Journal of Controlled Release 233, pages 57-63.
Crossref
Crossref
Catarina Carneiro, Alexandra Correia, Tânia Lima, Manuel Vilanova, Célia Pais, Andreia C. Gomes, M. Elisabete C.D. Real Oliveira & Paula Sampaio. (2016) Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis. Acta Biomaterialia 39, pages 133-145.
Crossref
Crossref
Yee Huang, Zhenguang Liu, Ruonan Bo, Jie Xing, Li Luo, Sisi Zhen, Yale Niu, Yuanliang Hu, Jiaguo Liu, Yi Wu & Deyun Wang. (2016) The enhanced immune response of PCV-2 vaccine using Rehmannia glutinosa polysaccharide liposome as an adjuvant. International Journal of Biological Macromolecules 86, pages 929-936.
Crossref
Crossref
Elisabeth Kastner & Yvonne Perrie. 2016. Analytical Techniques in the Pharmaceutical Sciences. Analytical Techniques in the Pharmaceutical Sciences
677
699
.
Faranak S. Nouri, Xing Wang, Xuguang Chen & Arash Hatefi. (2015) Reducing the Visibility of the Vector/DNA Nanocomplexes to the Immune System by Elastin-Like Peptides. Pharmaceutical Research 32:9, pages 3018-3028.
Crossref
Crossref
Tamilvanan Shunmugaperumal, Varinder Kaur & Raja Sekharan Thenrajan. 2015. Biofilm-based Healthcare-associated Infections. Biofilm-based Healthcare-associated Infections
147
189
.
Elisabeth Kastner, Signe T. Schmidt, Alexander Wilkinson, Dennis Christensen & Yvonne Perrie. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
77
94
.
Ruchi R Shah, Derek T O'Hagan, Mansoor M Amiji & Luis A Brito. (2014) The impact of size on particulate vaccine adjuvants. Nanomedicine 9:17, pages 2671-2681.
Crossref
Crossref
Ce Wang, Peng Liu, Yan Zhuang, Ping Li, Boling Jiang, Hong Pan, Lanlan Liu, Lintao Cai & Yifan Ma. (2014) Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory. Vaccine 32:42, pages 5475-5483.
Crossref
Crossref
Hayley Nehoff, Neha N. Parayath, Sebastien Taurin & Khaled Greish. 2014. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology
65
86
.
Caroline Lonez, Michel Bessodes, Daniel Scherman, Michel Vandenbranden, Virginie Escriou & Jean-Marie Ruysschaert. (2014) Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways. Nanomedicine: Nanotechnology, Biology and Medicine 10:4, pages 775-782.
Crossref
Crossref
Alexis García & Juan B. De Sanctis. (2014) An overview of adjuvant formulations and delivery systems. APMIS 122:4, pages 257-267.
Crossref
Crossref
Hengameh Firouzmand, Ali Badiee, Ali Khamesipour, Vahid Heravi Shargh, Seyedeh Hoda Alavizadeh, Azam Abbasi & Mahmoud Reza Jaafari. (2013) Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA). Acta Tropica 128:3, pages 528-535.
Crossref
Crossref
Dan Peer. (2013)
A daunting task: manipulating leukocyte function with
RNA
i
. Immunological Reviews 253:1, pages 185-197.
Crossref
Crossref
Zhenyu Zhong, Yougang Zhai, Shuang Liang, Yasuo Mori, Renzhi Han, Fayyaz S. Sutterwala & Liang Qiao. (2013) TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nature Communications 4:1.
Crossref
Crossref
Malou Henriksen-Lacey & Yvonne Perrie. 2013. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines
181
203
.
Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski & Istvan Toth. (2012) Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine 7:12, pages 1877-1893.
Crossref
Crossref
Paula Toimil, Gerardo Prieto, José Miñones Jr.José M. Trillo & Félix Sarmiento. (2012) Interaction of human serum albumin with monofluorinated phospholipid monolayers. Journal of Colloid and Interface Science 388:1, pages 162-169.
Crossref
Crossref
Dan Peer. (2012) Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles. Advanced Drug Delivery Reviews 64:15, pages 1738-1748.
Crossref
Crossref
Caroline Lonez, Michel Vandenbranden & Jean-Marie Ruysschaert. (2012) Cationic lipids activate intracellular signaling pathways. Advanced Drug Delivery Reviews 64:15, pages 1749-1758.
Crossref
Crossref
Dalit Landesman-Milo & Dan Peer. (2012) Altering the immune response with lipid-based nanoparticles. Journal of Controlled Release 161:2, pages 600-608.
Crossref
Crossref
Ulrike Lambertz, Judith Maxwell Silverman, Devki Nandan, W Robert McMaster, Joachim Clos, Leonard J Foster & Neil E Reiner. (2012) Secreted virulence factors and immune evasion in visceral leishmaniasis. Journal of Leukocyte Biology 91:6, pages 887-899.
Crossref
Crossref
Rogério Silva Rosada, Célio Lopes Silva, Maria Helena Andrade Santana, Clóvis Ryuichi Nakaie & Lucimara Gaziola de la Torre. (2012) Effectiveness, against tuberculosis, of pseudo-ternary complexes: Peptide-DNA-cationic liposome. Journal of Colloid and Interface Science 373:1, pages 102-109.
Crossref
Crossref
Hong Yu, Karuna P. Karunakaran, Xiaozhou Jiang, Caixia Shen, Peter Andersen & Robert C. Brunham. (2012) Chlamydia muridarum T Cell Antigens and Adjuvants That Induce Protective Immunity in Mice. Infection and Immunity 80:4, pages 1510-1518.
Crossref
Crossref
Yan Zhuang, Yifan Ma, Ce Wang, Luo Hai, Chao Yan, Yijuan Zhang, Fengzhi Liu & Lintao Cai. (2012) PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. Journal of Controlled Release 159:1, pages 135-142.
Crossref
Crossref
Douglas S. Watson, Aaron N. Endsley & Leaf Huang. (2012) Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 30:13, pages 2256-2272.
Crossref
Crossref
Camilla Foged, Jon Hansen & Else Marie Agger. (2012) License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems. European Journal of Pharmaceutical Sciences 45:4, pages 482-491.
Crossref
Crossref
Anders Fomsgaard, Ingrid Karlsson, Gregers Gram, Christian Schou, Sheila Tang, Peter Bang, Ingrid Kromann, Peter Andersen & Lars Vibe Andreasen. (2011) Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01. Vaccine 29:40, pages 7067-7074.
Crossref
Crossref
Camilla Foged. (2011) Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Therapeutic Delivery 2:8, pages 1057-1077.
Crossref
Crossref
Gerd Lipowsky & Martin F. Bachmann. 2011. Development of Vaccines. Development of Vaccines
19
63
.
Myrra G. Carstens, Marcel G.M. Camps, Malou Henriksen-Lacey, Kees Franken, Tom H.M. Ottenhoff, Yvonne Perrie, Joke A. Bouwstra, Ferry Ossendorp & Wim Jiskoot. (2011) Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine 29:29-30, pages 4761-4770.
Crossref
Crossref
Sarah E. McNeil, Ida Rosenkrands, Else Marie Agger, Peter Andersen & Yvonne Perrie. (2011) Subunit Vaccines: Distearoylphosphatidylcholine-Based Liposomes Entrapping Antigen Offer a Neutral Alternative to Dimethyldioctadecylammonium-Based Cationic Liposomes as an Adjuvant Delivery System. Journal of Pharmaceutical Sciences 100:5, pages 1856-1865.
Crossref
Crossref
Malou Henriksen-Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Andersen & Yvonne Perrie. (2010)
Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[
N
-(
N
′,
N
′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 Responses
. Molecular Pharmaceutics 8:1, pages 153-161.
Crossref
Crossref
Yifan Ma, Yan Zhuang, Xiaofang Xie, Ce Wang, Fei Wang, Dongmei Zhou, Jianqiang Zeng & Lintao Cai. (2011) The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses. Nanoscale 3:5, pages 2307.
Crossref
Crossref
Stefaan De Koker, Bart N. Lambrecht, Monique A. Willart, Yvette van Kooyk, Johan Grooten, Chris Vervaet, Jean Paul Remon & Bruno G. De Geest. (2011) Designing polymeric particles for antigen delivery. Chem. Soc. Rev. 40:1, pages 320-339.
Crossref
Crossref
Himanshu Agrawal, Nipa Thacker & Ambikanandan Misra. 2011. Challenges in Delivery of Therapeutic Genomics and Proteomics. Challenges in Delivery of Therapeutic Genomics and Proteomics
531
622
.
Tae-Hyun Paik, Ji-Sook Lee, Ki-Hye Kim, Chul-Su Yang, Eun-Kyeong Jo & Chang-Hwa Song. (2010) Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation. Vaccine 28:50, pages 7873-7880.
Crossref
Crossref
Tamilvanan Shunmugaperumal. 2010. Biofilm Eradication and Prevention. Biofilm Eradication and Prevention
337
358
.
Malou Henriksen-Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Andersen & Yvonne Perrie. (2010) Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. Journal of Controlled Release 145:2, pages 102-108.
Crossref
Crossref
Malou Henriksen-Lacey, Vincent W. Bramwell, Dennis Christensen, Else-Marie Agger, Peter Andersen & Yvonne Perrie. (2010) Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. Journal of Controlled Release 142:2, pages 180-186.
Crossref
Crossref
Mei Lin Tan, P.F.M. Choong & C.R. Dass. (2010) Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 31:1, pages 184-193.
Crossref
Crossref
Swati Bhowmick, Tuhina Mazumdar, Roma Sinha & Nahid Ali. (2010) Comparison of liposome based antigen delivery systems for protection against Leishmania donovani. Journal of Controlled Release 141:2, pages 199-207.
Crossref
Crossref
Jean Haensler. 2010. Vaccine Adjuvants. Vaccine Adjuvants
73
90
.
Luis G. Bermúdez-Humarán & Philippe Langella. (2009) Utilisation des bactéries lactiques comme vecteurs vaccinaux. Revue Francophone des Laboratoires 2009:417, pages 79-89.
Crossref
Crossref
Dennis Christensen, Karen Korsholm, Grith Krøyer Wood, Afzal Mohammed, Vincent Bramwell, Peter Andersen, Else Marie Agger & Yvonne Perrie. 2009. Delivery Technologies for Biopharmaceuticals. Delivery Technologies for Biopharmaceuticals
357
376
.
Camilla Foged, Pieter Vader & Raymond M. Schiffelers. 2009. Delivery Technologies for Biopharmaceuticals. Delivery Technologies for Biopharmaceuticals
291
304
.
H. Martin Vordermeier, Gillian S. Dean, Ida Rosenkrands, Else M. Agger, Peter Andersen, Daryan A. Kaveh, R. Glyn Hewinson & Philip J. Hogarth. (2009) Adjuvants Induce Distinct Immunological Phenotypes in a Bovine Tuberculosis Vaccine Model. Clinical and Vaccine Immunology 16:10, pages 1443-1448.
Crossref
Crossref
Shui-Hua ZHANG, Jia-Xu LIANG, Shu-Yan DAI, Xiao-Lin QIU, Yan-Rong YI & Yun PAN. (2009) Immunological Effect of Subunit Influenza Vaccine Entrapped by Liposomes. Biomedical and Environmental Sciences 22:5, pages 388-393.
Crossref
Crossref
Gregers Jacob Gram, Ingrid Karlsson, Else Marie Agger, Peter Andersen & Anders Fomsgaard. (2009) A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8+ Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice. PLoS ONE 4:9, pages e6950.
Crossref
Crossref
Caroline Lonez, Marc F. Lensink, Michel Vandenbranden & Jean-Marie Ruysschaert. (2009) Cationic lipids activate cellular cascades. Which receptors are involved?. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:6, pages 425-430.
Crossref
Crossref
Kenneth C. McCullough & Artur Summerfield. (2009) Targeting the porcine immune system—Particulate vaccines in the 21st century. Developmental & Comparative Immunology 33:3, pages 394-409.
Crossref
Crossref
Joe Inoue, Ryuichi Ideue, Daisuke Takahashi, Masahiro Kubota & Yoshio Kumazawa. (2009) Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway. Journal of Controlled Release 133:1, pages 18-23.
Crossref
Crossref
Robert L. Atmar & Wendy A. Keitel. 2009. Vaccines for Pandemic Influenza. Vaccines for Pandemic Influenza
323
344
.
Luis G. Bermúdez-Humarán, Silvia Innocentin, Francois Lefèvre, Jean-Marc Chatel & Philippe Langella. 2009. Prebiotics and Probiotics Science and Technology. Prebiotics and Probiotics Science and Technology
1099
1122
.
Jon Hansen, Klaus Thorleif Jensen, Frank Follmann, Else Marie Agger, Michael Theisen & Peter Andersen. (2008)
Liposome Delivery of
Chlamydia muridarum
Major Outer Membrane Protein Primes a Th1 Response That Protects against Genital Chlamydial Infection in a Mouse Model1
. The Journal of Infectious Diseases 198:5, pages 758-767.
Crossref
Crossref
Caroline Lonez, Michel Vandenbranden & Jean-Marie Ruysschaert. (2008) Cationic liposomal lipids: From gene carriers to cell signaling. Progress in Lipid Research 47:5, pages 340-347.
Crossref
Crossref
Kim S. Jones. (2008) Biomaterials as vaccine adjuvants. Biotechnology Progress 24:4, pages 807-814.
Crossref
Crossref
Shunmugaperumal Tamilvanan, Narayanan Venkateshan & Annick Ludwig. (2008) The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. Journal of Controlled Release 128:1, pages 2-22.
Crossref
Crossref